688298 Stock Overview
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Zhejiang Orient Gene Biotech Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥29.56 |
52 Week High | CN¥49.35 |
52 Week Low | CN¥25.00 |
Beta | 1.74 |
1 Month Change | -3.18% |
3 Month Change | 13.21% |
1 Year Change | -37.98% |
3 Year Change | -69.85% |
5 Year Change | n/a |
Change since IPO | -65.98% |
Recent News & Updates
Shareholder Returns
688298 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 6.5% | 2.6% | 1.2% |
1Y | -38.0% | -19.6% | -12.6% |
Return vs Industry: 688298 underperformed the CN Biotechs industry which returned -19.6% over the past year.
Return vs Market: 688298 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
688298 volatility | |
---|---|
688298 Average Weekly Movement | 6.7% |
Biotechs Industry Average Movement | 7.7% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.1% |
10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 688298 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688298's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 2,242 | Xiaoliang Fang | www.orientgene.com |
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products.
Zhejiang Orient Gene Biotech Co.,Ltd Fundamentals Summary
688298 fundamental statistics | |
---|---|
Market cap | CN¥5.96b |
Earnings (TTM) | -CN¥414.61m |
Revenue (TTM) | CN¥627.03m |
9.5x
P/S Ratio-14.4x
P/E RatioIs 688298 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688298 income statement (TTM) | |
---|---|
Revenue | CN¥627.03m |
Cost of Revenue | CN¥338.19m |
Gross Profit | CN¥288.85m |
Other Expenses | CN¥703.45m |
Earnings | -CN¥414.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -2.06 |
Gross Margin | 46.07% |
Net Profit Margin | -66.12% |
Debt/Equity Ratio | 2.3% |
How did 688298 perform over the long term?
See historical performance and comparison